Short interposition with a small-diameter prosthetic graft for flow reduction of a high-flow arteriovenous fistula.
Arteriovenous Shunt, Surgical
/ methods
Blood Vessel Prosthesis
Brachial Artery
/ physiopathology
Brachiocephalic Veins
/ physiopathology
Female
Humans
Kidney Failure, Chronic
/ therapy
Male
Middle Aged
Regional Blood Flow
/ physiology
Renal Dialysis
/ methods
Retrospective Studies
Vascular Patency
/ physiology
End-stage renal disease
High-flow arteriovenous fistula
Retrospective review
Short interposition
Vascular access
Journal
Journal of vascular surgery
ISSN: 1097-6809
Titre abrégé: J Vasc Surg
Pays: United States
ID NLM: 8407742
Informations de publication
Date de publication:
01 2021
01 2021
Historique:
received:
08
10
2019
accepted:
03
05
2020
pubmed:
31
5
2020
medline:
4
5
2021
entrez:
31
5
2020
Statut:
ppublish
Résumé
The objective of this study was to evaluate the outcome of a short interposition using a small-diameter prosthetic graft as a flow-limiting procedure to manage symptomatic high-flow arteriovenous fistula (AVF). A retrospective review of medical records on a case series was conducted. From June 2004 to April 2017, there were 25 patients with clinical symptoms of high output cardiac failure and progressive dilation of aneurysmal fistula vein due to high-flow AVF (≥1.5 L/min) who underwent short interposition with a 5-mm prosthetic graft at Saitama Medical Center. The primary outcome was the relief of clinical symptoms; other outcome measures included technical success, surgical complications, patency of vascular access, and postoperative changes in local and systemic hemodynamics as assessed by Doppler ultrasound. Twenty-five patients underwent short interposition for cardiac indications (n = 16) and aneurysmal dilation (n = 9). The technical success rate was 100%. The clinical symptoms were relieved in 24 patients (96.0%). Mean reduction in access blood flow was 52.4%. Cumulative primary unassisted patency rates (± standard error) at 1 year, 2 years, and 3 years were 76.2% ± 9.3%, 70.4% ± 10.3%, and 58.1% ± 11.6%, respectively. Secondary patency rates (± standard error) at 1 year, 2 years, and 3 years were 81.8% ± 8.2%, 71.5% ± 9.9%, and 71.5% ± 9.9%, respectively. Complications included access occlusion due to late thrombosis (n = 5 [21.7%]) and graft infection (n = 1 [4.3%]) in the median follow-up period of 3.9 years. Short interposition with a prosthetic graft is a simple, effective, and durable treatment option for end-stage renal disease patients with cardiac symptoms and progressive dilation of the fistula vein due to high-flow AVF, offering clinical symptom resolution while preserving the autologous behavior of the initial access.
Identifiants
pubmed: 32473337
pii: S0741-5214(20)31291-X
doi: 10.1016/j.jvs.2020.05.035
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
285-290Informations de copyright
Copyright © 2020 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.